Aberdeen Group’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.6M Buy
710,238
+26,113
+4% +$940K 0.04% 320
2026
Q1
$22M Buy
684,125
+100,241
+17% +$3.56M 0.04% 401
2025
Q4
$21M Buy
583,884
+41,018
+8% +$1.51M 0.03% 412
2025
Q3
$17.1M Buy
542,866
+333,649
+159% +$12M 0.03% 481
2025
Q2
$8.9M Buy
+209,217
New +$8.7M 0.02% 623

Other funds holding VCEL

Aberdeen Group's VCEL Position: Q2 2026 in Review

Aberdeen Group increased its Vericel Corp (VCEL) stake by 3.8% in Q2 2026, buying an estimated $940K and bringing the position to 710,238 shares worth $31.6M. The position accounts for 0.04% of the portfolio, ranked #320.

Aberdeen Group first reported a position in VCEL in Q2 2025 and has held it in 5 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Aberdeen Group held 710,238 shares of Vericel Corp worth $31.6M as of Q2 2026.
  • Aberdeen Group bought 26,113 Vericel Corp shares in Q2 2026, an estimated $940K.
  • Vericel Corp made up 0.04% of Aberdeen Group's portfolio in Q2 2026, its #320 holding.
  • Aberdeen Group first reported a position in Vericel Corp in Q2 2025 and has held it in 5 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.